Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367431 · ClinicalTrials.gov registry record
Xanthohumol and Metabolic Syndrome
A clinical trial, sponsored by Oregon State University.
- Completed
- Registry status
- 48
- Enrollment target
NCT01367431 is a clinical trial that has completed, run by Oregon State University. The registered enrollment target is 48 participants.
The verdict
NCT01367431 has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetics (PK) of xanthohumol (XN). Small amounts of xanthohumol occur naturally in hops, used to make beer, and XN is also found in beer itself. Studies in animals have shown that XN can lower blood sugar and blood lipids such as triglycerides, which can contribute to heart disease. The purpose of this study is to see how much of the XN is absorbed into the blood and how fast it leaves the body when taken by mouth. Once the PK study has been done, the investigators' long-term goal is to learn if xanthohumol can lower risk factors for heart disease and type-2 diabetes in humans.
Interventions
- DIETARY_SUPPLEMENT Xanthohumol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01367431
The ClinicalTrials.gov registry entry for NCT01367431 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon State University, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Xanthohumol is the first listed.
NCT01367431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01367431 about?
NCT01367431 is a clinical study titled "Xanthohumol and Metabolic Syndrome". The purpose of this study is to determine the pharmacokinetics (PK) of xanthohumol (XN). Small amounts of xanthohumol occur naturally in hops, used to make beer, and XN is also found in beer itself. Studies in animals have shown that XN can lower blood sugar and blood lipids such as triglycerides, w...
What is the current status of trial NCT01367431?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2011-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01367431?
The interventions under investigation include: Xanthohumol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01367431?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.